What is OncoTICE used for in bladder cancer?

OncoTICE treats primary or concurrent bladder carcinoma-in-situ and prevents recurrence after transurethral resection of high-grade and/or relapsing superficial papillary transitional cell carcinoma (Ta grades 2–3 or T1 grades 1–3); Ta grade 1 papillary tumours qualify only when recurrence risk is judged high.